Ovid Therapeutics (OVID)
(Delayed Data from NSDQ)
$0.87 USD
+0.04 (5.31%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $0.89 +0.02 (1.83%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/02/2024
Time: -- |
6/2024 | $-0.22 | 3.87% |
Earnings Summary
For their last quarter, Ovid Therapeutics (OVID) reported earnings of -$0.17 per share, beating the Zacks Consensus Estimate of $-0.23 per share. This reflects a positive earnings surprise of 26.09%. Look out for OVID's next earnings release expected on August 02, 2024. For the next earning release, we expect the company to report earnings of -$0.22 per share, reflecting a year-over-year decrease of 22.22%.
Earnings History
Price & Consensus
Zacks News for OVID
OVID Slumps 76% on Epilepsy Drug Failing Two Pivotal Studies
OVID: What are Zacks experts saying now?
Zacks Private Portfolio Services